Determination of Synacthen in urine for sports drug testing by means of nano-ultra-performance liquid chromatography/tandem mass spectrometry

Rapid Communications in Mass Spectrometry

Volumn 23, Issue 17, 2009, Pages 2669-2674

  Thomas, Andreas ^a   Kohler, Maxie ^a   Schänzer, Wilhelm ^a   Kamber, Matthias ^b   Delahaut, Philippe ^c   Thevis, Mario ^a  

^a GERMAN SPORT UNIVERSITY COLOGNE   (Germany)

^b Federal Office of Sports   (Switzerland)

^c Laboratoire d'Hormonologie   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN-ANTIBODY REACTIONS; BODY FLUIDS; CONTROLLED DRUG DELIVERY; DRUG PRODUCTS; HIGH PRESSURE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY;

ADRENOCORTICOTROPIC HORMONES; DOPING CONTROL ANALYSIS; DRUG TESTING; HALF LIVES; LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY; LIQUID CHROMATOGRAPHY/TANDEM MASS SPECTROMETRY; MODERN SPORTS; PERFORMANCE ENHANCING; TARGET CONCENTRATIONS; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY;

SPORTS;

EID: 69249108718     PISSN: 09514198     EISSN: 10970231     Source Type: Journal    
DOI: 10.1002/rcm.4176     Document Type: Article

References (22)

1. Baker JR, Bennett HP, Hudson AM, McMartin C, Purdon GE. Clin. Endocrinol. (Oxf.) 1976; 5 (Suppl): 61S.
2. Baker JR, Bennett HP, Christian. RA, McMartin C. J. Endocrinol. 1977; 74: 23.
3. Alia P, Villabona C, Gimenez O, Sospedra E, Soler J, Navarro MA. Clin. Endocrinol. (Oxf.) 2006; 65: 346.
4. Crowley S, Hindmarsh PC, Holownia P, Honour JW, Brook CG. J. Endocrinol. 1991; 130: 475.
5. Vogeser M, Zachoval R, Jacob K. Clin. Biochem. 2001; 34: 421.
6. Yoshida-Hiroi M, Tsuchida Y, Yoshino G, Hiroi N. Horm. Metab. Res. 2005; 37: 489.
7. Wuthrich P, Martenet M, Buri P. Pharm. Res. 1994; 11: 278.
8. Thevis M, Bredehöft M, Geyer H, Kamber M, Delahaut P, Schänzer W. Rapid Commun. Mass Spectrom. 2006; 20: 3551.
9. Baume N, Steel G, Edwards T, Thorstensen E, Miller BF. Eur. J. Appl. Physiol. 2008; 104: 589.
10. Thomas A, Schänzer W, Kamber M, Thevis M. Drug Test. Anal. 2009; accepted. DOI: 10.1002/dta.35
11. Thevis M, Thomas A, Schänzer W. Mass Spectrom. Rev. 2008; 27: 35.
12. Bredehöft M, Schänzer W, Thevis M. Rapid Commun. Mass Spectrom. 2008; 22: 477.
13. Thevis M, Kuuranne T, Geyer H, Schänzer W. Drug Test. Anal. 2009; 1: 4.
14. Sholar MB, Mendelson JH, Mello NK, Siegel AJ, Kaufman MJ, Levin JM, Renshaw PF, Cohen BM. J. Clin. Endocrinol. Metab. 1998; 83: 966.
15. Bickel U, Born J, Fehm HL, Distler M, Voigt KH. Eur. J. Clin. Pharmacol. 1988; 35: 371.
16. Wilm M, Mann M. Anal. Chem. 1996; 68: 1.
17. Noga M, Sucharski F, Suder P, Silberring J. J. Sep. Sci. 2007; 30: 2179.
18. Thomas A, Geyer H, Kamber M, Schänzer W, Thevis M. J. Mass Spectrom. 2008; 43: 908.
19. Thevis M, Loo JA, Loo RR, Schänzer W. Rapid Commun. Mass Spectrom. 2007; 21: 297.
20. Kim YH, Berry AH, Spencer DS, Stites WE. Protein Eng. 2001; 14: 343.
21. Houghten RA, Li CH. Methods Enzymol. 1983; 91: 549.
22. Houghten RA, Li CH. Anal. Biochem. 1979; 98: 36.